ARCHIVES

FDA Discloses Responses, Toxicities For Burzynski’s “Antineoplastons”

This article is from The Cancer Letter archive.

Vol. 24 No. 16 | April 24, 1998

Download PDF Visit The Full Archive

Related Articles

In Brief: Jane Henney, Former NCI Deputy Director, Named FDA Deputy Commissioner For Operations

November 15, 1991

NCI Advisors Reject $30-Million Cohort Study, Approve Renewal of Phase I Clinical Trials Initiatives and American College of Radiology Imaging Network.

July 7, 2006

Marvin Schneiderman To Retire March 1

February 8, 1980

ORI takes Over Misconduct Inquiry Of NSABP Officials

July 29, 1994

Includes May issue of Business & Regulatory Report.

May 31, 2002

Rauscher Says He May Leave, But Will Stay Through June

February 6, 1976